Error: Parsing failed at character position 360 near "H1A1表达增加（p <0.05，n ="
Parsing failed at character position 427 near "以克服TMZ诱导的化学抗性的理论基础。"
<rich-text nodes="{{Helper.getLanguage(item.Content,values[1])}}" selectable="true" class="articleContent" />
[ { "Title": [ [ "替莫唑胺通过上调PD-L1促进GBM细胞的免疫逃逸。", "Temozolomide promotes immune escape of GBM cells via upregulating PD-L1." ] ], "Content": [ [ "多形性胶质母细胞瘤（GBM）是最常见的恶性原发性脑肿瘤，预后不良，目前有效的治疗策略仍然有限。", "Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor with poor prognosis, and currently effective therapeutic strategies are still limited." ], [ "虽然替莫唑胺（TMZ）常用于GBM治疗，其作用机制已得到很好的表征，但其副作用需要全面研究。", "Although temozolomide (TMZ) is commonly used for GBM therapy and its mechanism was well characterized, while its side effects were required comprehensive investigation." ], [ "在本研究中，我们发现TMZ攻击的GBM细胞强烈抑制激活的外周血单核细胞（PBMC）中的促炎细胞因子表达，这依赖于增强的CD274转录（编码PD-L1），但不依赖于其他免疫检查点，", "In the present study, we revealed that TMZ-challenged GBM cells strongly suppressed pro-inflammatory cytokines expression in activated periphery blood mononuclear cells (PBMC), which depended on enhanced transcription of CD274 (encoding PD-L1), but not other immune checkpoints," ], [ "例如CD276，HVEM和galectin-9。", "such as CD276, HVEM and galectin-9." ], [ "此外，在TMZ处理的GBM细胞中，膜PD-L1的丰度也增加。", "Moreover, abundance of membranous PD-L1 was also increased in TMZ-treated GBM cells." ], [ "当短发夹RNA（shRNA）敲低PD-L1表达时，TMZ处理的GBM细胞对PBMC的抑制作用变弱，表明PD-L1对TMZ处理的GBM细胞的免疫抑制能力至关重要。", "When PD-L1 expression was knocked down by short hairpin RNA (shRNA), inhibitory effect of TMZ-treated GBM cells on PBMC became weakened, suggesting that PD-L1 was crucial for immune inhibition capacity of TMZ-treated GBM cells." ], [ "另外，放线菌素D在TMZ攻击后降低GBM细胞中的PD-L1表达，表明PD-L1诱导发生在转录水平。", "Additionally, actinomycin D reduced PD-L1 expression in GBM cells after TMZ challenge, indicating that PD-L1 induction occurred at transcriptional level." ], [ "免疫印迹结果表明STAT3信号传导参与TMZ介导的PD-L1诱导，并且使用STAT3抑制剂VI或STAT3shRNA观察到PD-L1的减毒表达。", "The immunoblotting results demonstrated that STAT3 signaling was involved in TMZ-mediated PD-L1 induction, and attenuated expression of PD-L1 was observed using STAT3 inhibitor VI or STAT3 shRNA." ], [ "最后，动物研究表明，TMZ和PD-1抗体疗法的组合强烈抑制肿瘤生长并实现GBM小鼠的存活率提高。", "Finally, the animal study showed that combination of TMZ and PD-1 antibody therapy strongly inhibited tumor growth and achieved the improved survival rate of GBM mice." ], [ "因此，本研究揭示了经典化疗药物TMZ促进GBM细胞免疫逃逸，即使TMZ联合PD-1抗体治疗也未进一步提高复发性GBM患者的生存率，与传统治疗方法相比，而我们的动物研究提供了证据表明TMZ的组合", "Accordingly, this study revealed the classical chemotherapy drug TMZ promoted GBM cells immune escape, even TMZ combine with PD-1 antibody treatment not further improve survival ratio of recurrent GBM patients compared with traditional therapy methods, while our animal study provided evidence that combination of TMZ" ], [ "和PD-1抗体是治疗GBM的一种有前景的方法，这些相互矛盾的结果表明，提高PD-1抗体的递送效率可以发挥强大的联合治疗效果。", "and PD-1 antibody was a promising way to treat GBM, these contradictory results indicate improving the PD-1 antibody delivery efficiency can exert strong combinational therapy outcomes." ] ], "UID": "31285949", "Date": "2019-07-11", "Links": { "pubmed": "31285949", "pmc": "PMC6610056" }, "Authors": "Silu.Wang,Fuli.Yao,Xianghe.Lu,Qun.Li,Zhipeng.Su,Jong-Ho.Lee,Chengde.Wang,Linyong.Du", "JournalTitle": "American journal of cancer research" }, { "Title": [ [ "对EGFR抑制的抗性机制揭示了人GBM中的代谢脆弱性。", "Mechanisms of resistance to EGFR inhibition reveal metabolic vulnerabilities in human GBM." ] ], "Content": [ [ "表皮生长因子受体基因（EGFR）的扩增代表胶质母细胞瘤（GBM）中最常见的遗传病变之一，然而，靶向该信号传导途径的疗法在临床上失败。", "Amplification of the epidermal growth factor receptor gene (EGFR) represents one of the most commonly observed genetic lesions in glioblastoma (GBM), however, therapies targeting this signaling pathway have failed clinically." ], [ "在这里，使用人类肿瘤，原发性患者来源的异种移植物（PDX）和GBM的鼠模型，我们证明EGFR抑制导致肿瘤细胞的侵袭增加。", "Here, using human tumors, primary patient-derived xenografts (PDXs), and a murine model for GBM, we demonstrate that EGFR inhibition leads to increased invasion of tumor cells." ], [ "此外，EGFR抑制剂处理的GBM表现出改变的氧化应激，增加的脂质过氧化作用和产生有毒的脂质过氧化产物。", "Further, EGFR inhibitor-treated GBM demonstrate altered oxidative stress, with increased lipid peroxidation, and generation of toxic lipid peroxidation products." ], [ "确定具有升高的醛脱氢酶（ALDH）水平的肿瘤细胞亚群包含在EGFR抑制剂处理的GBM中观察到的显着比例的侵袭性细胞。", "A tumor cell subpopulation with elevated aldehyde dehydrogenase (ALDH) levels were determined to comprise a significant proportion of the invasive cells observed in EGFR inhibitor-treated GBM." ], [ "我们对新诊断的GBM中ALDH1A1蛋白的分析显示，在69％（35/51）的病例中可检测到ALDH1A1表达，但肿瘤细胞的百分比相对较低。", "Our analysis of ALDH1A1 protein in newly diagnosed GBM revealed detectable ALDH1A1 expression in 69% (35/51) of the cases, but in relatively low percentages of tumor cells." ], [ "对EGFR抑制剂治疗前后配对的人GBM的分析显示EGFR扩增的肿瘤中ALDH1A1表达增加（p <0.05，n = 13个肿瘤对），并且在鼠GBM中ALDH1A1-高克隆比ALDH1A1对EGFR抑制更具抗性。", "Analysis of paired human GBM before and after EGFR inhibitor therapy showed an increase in ALDH1A1 expression in EGFR-amplified tumors (p<0.05, n=13 tumor pairs), and in murine GBM ALDH1A1-high clones were more resistant to EGFR inhibition than ALDH1A1" ], [ "低克隆。", "-low clones." ], [ "我们的数据将ALDH水平鉴定为具有高侵袭能力，改变的氧化应激和对EGFR抑制的抗性的GBM细胞的生物标志物，并揭示其抑制应限制GBM侵袭的治疗靶标。", "Our data identify ALDH levels as a biomarker of GBM cells with high invasive potential, altered oxidative stress, and resistance to EGFR inhibition, and reveal a therapeutic target whose inhibition should limit GBM invasion." ] ], "UID": "31270152", "Date": "2019-07-23", "Links": { "pubmed": "31270152", "pii": "1535-7163.MCT-18-1330", "doi": "10.1158/1535-7163.MCT-18-1330" }, "Authors": "Andrew.McKinney,Olle R.Lindberg,Jane R.Engler,Katharine Y.Chen,Anupam.Kumar,Henry.Gong,Kan V.Lu,Erin F.Simonds,Timothy F.Cloughesy,Linda M.Liau,Michael.Prados,Andrew W.Bollen,Mitchel S.Berger,Joseph T C.Shieh,C David.James,Theodore P.Nicolaides,William H.Yong,Albert.Lai,Monika E.Hegi,William A.Weiss,Joanna J.Phillips", "JournalTitle": "Molecular cancer therapeutics" }, { "Title": [ [ "替莫唑胺抗性原代GBM干细胞样细胞和复发性GBM的比较转录组学分析鉴定碳酸酐酶CA2基因作为抗性因子的上调。", "Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase <i>CA2</i> Gene as Resistance Factor." ] ], "Content": [ [ "大约95％的胶质母细胞瘤（GBM）患者显示肿瘤复发，使他们的治疗选择有限，因为复发性肿瘤最常耐受一线化疗标准替莫唑胺（TMZ）。", "About 95% of patients with Glioblastoma (GBM) show tumor relapse, leaving them with limited therapeutic options as recurrent tumors are most often resistant to the first line chemotherapy standard Temozolomide (TMZ)." ], [ "为了鉴定涉及TMZ抗性的分子途径，分离，表征和选择原代GBM干细胞样细胞（GSC）用于体外TMZ抗性。", "To identify molecular pathways involved in TMZ resistance, primary GBM Stem-like Cells (GSCs) were isolated, characterized, and selected for TMZ resistance in vitro." ], [ "随后，进行RNA测序分析并显示在TMZ抗性干细胞样细胞中总共49个差异表达的基因（| log2倍变化|> 0.5并且调整的<p> - 值<0.1）。", "Subsequently, RNA sequencing analysis was performed and revealed a total of 49 differentially expressed genes (|log2-fold change| > 0.5 and adjusted <i>p</i>-value < 0.1) in TMZ resistant stem-like cells compared" ], [ "到他们匹配的DMSO对照细胞。", "to their matched DMSO control cells." ], [ "在上调基因中，我们将碳酸酐酶2（CA2）鉴定为与胶质瘤恶性肿瘤和患者存活相关的候选基因。", "Among up-regulated genes, we identified carbonic anhydrase 2 (CA2) as a candidate gene correlated with glioma malignancy and patient survival." ], [ "值得注意的是，我们描述了CA2不仅在TMZ抗性GSC中对mRNA和蛋白质水平的一致上调，而且在患者匹配的第一次出现和复发肿瘤的临床样本中也是如此。", "Notably, we describe consistent up-regulation of CA2 not only in TMZ resistant GSCs on mRNA and protein level, but also in patient-matched clinical samples of first manifest and recurrent tumors." ], [ "与碳酸酐酶抑制剂乙酰唑胺（ACZ）共处理使细胞对TMZ诱导的细胞死亡敏感。", "Co-treatment with the carbonic anhydrase inhibitor Acetazolamid (ACZ) sensitized cells to TMZ induced cell death." ], [ "累积地，我们的发现说明了CA2作为复发性GBM中的化学增敏靶标的潜力，并提供了治疗相关的抑制CA2以克服TMZ诱导的化学抗性的理论基础。", "Cumulatively, our findings illustrate the potential of CA2 as a chemosensitizing target in recurrent GBM and provide a rationale for a therapy associated inhibition of CA2 to overcome TMZ induced chemoresistance." ] ], "UID": "31262047", "Date": "2019-07-02", "Links": { "pubmed": "31262047", "pii": "cancers11070921", "doi": "10.3390/cancers11070921" }, "Authors": "Ricarda.Hannen,Martin.Selmansberger,Maria.Hauswald,Axel.Pagenstecher,Andrea.Nist,Thorsten.Stiewe,Till.Acker,Barbara.Carl,Christopher.Nimsky,Jörg Walter.Bartsch", "JournalTitle": "Cancers" } ] |
同问，解决了么这个问题。楼主
我也有同样的问题
请问，问题解决了吗 我也遇到了同样的问题
这是我富文本的内容
<p><span style="color: rgb(51, 51, 51); font-family: arial, 宋体, sans-serif; font-size: 14px; text-indent: 28px; background-color: rgb(255, 255, 255);">上海绿地物业服务有限公司成立于2010年，</span><a target="_blank" href="https://baike.baidu.com/item/%E7%BB%BF%E5%9C%B0%E9%9B%86%E5%9B%A2/2942731" style="color: rgb(19, 110, 194); text-decoration-line: none; font-family: arial, 宋体, sans-serif; font-size: 14px; text-indent: 28px; white-space: normal; background-color: rgb(255, 255, 255);">绿地集团</a><span style="color: rgb(51, 51, 51); font-family: arial, 宋体, sans-serif; font-size: 14px; text-indent: 28px; background-color: rgb(255, 255, 255);">下属全资子公司，中国物业管理协会理事单位，上海市物业行业协会常务理事单位，济南市物业管理协会理事单位，上海市物业管理行业诚信承诺A级企业，国家二级资质物业服务企业，绿地物业在上海、济南、广州等地设立分公司，在管项目及前期签约面积300万平方米。是以绿地集团开发的城市综合体、超高层建筑、超甲级写字楼、购物中心、公寓为主的专业物业公司。</span></p>
请问，问题解决了吗？我也遇到了同样的问题。